Immunization of rabbits with secific components of postsynaptic membrane. Acetylcholinesterase and cholinergic receptor.
Rabbits were immunized versus either an acetylcholinesterase- or a cholinergic receptor-rich fraction isolated from the electric organ of Torpedo marmorata. In both groups of animals we obtained a production of specific antibodies detected by immunodiffusion without cross reaction for the two antigens. Only rabbits immunized with the receptor-rich fraction developed a progressive flaccid paralysis, which affected first the leg muscles, progressively the neck muscles and eventually the respiratory muscles. The paralysis lasted in several animals up to 20 days. Eserine reversed the paralysis only in the first days but was ineffective in the "chronic" stage of the disease. In these animals high frequency stimulation of sciatic nerve induced a rapid failure of the responses of the anterior tibialis muscle while the muscle responded normally to a direct stimulation. A period of rest allowed a complete recovery of the muscle from fatigue. Tetani did not evoke the post-tetanic potentiation. Abnormalities, such as lymphocytic infiltration, fibers atrophy and necrosis, smearing and widening of Z line were sometimes present in muscles of Cho-R-immunized rabbits. In ACh-E immunized animals the neuromuscular transmission and the muscle morphology were similar to that of normal animals. Glycogen, ATP, cytochrome C oxidase, phosphorylases and acetylcholinesterase did not change significantly in the muscles of the immunized animals, while a large increase of cholineacetyltransferase activity was present. Red blood cell acetylcholinesterase showed a particularly high activity in ACh-E-immunized animals. The autoimmune paralysis induced in Cho-R-immunized rabbits may be a useful experimental model for further studies on human myasthenia gravis.
D000110:Acetylcholinesterase / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004557:Electric Organ; D004558:Electric Stimulation; D003576:Electron Transport Complex IV / Q000378:metabolism; D005260:Female; D006003:Glycogen / Q000378:metabolism; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000473:pathology / Q000503:physiopathology / Q000648:ultrastructure; D009157:Myasthenia Gravis / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000503:physiopathology; D006005:Phosphorylases / Q000378:metabolism; D010830:Physostigmine / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D011950:Receptors, Cholinergic; D013570:Synaptic Membranes / Q000276:immunology*
D011950:Receptors, Cholinergic; D006003:Glycogen; D010830:Physostigmine; D003576:Electron Transport Complex IV; D002795:Choline O-Acetyltransferase; D006005:Phosphorylases; D000110:Acetylcholinesterase